Submitted by Anonymous (not verified) on 2 June 2025 - 15:54
Human medicines European public assessment report (EPAR): Camzyos, mavacamten, Date of authorisation: 26/06/2023, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Camzyos, mavacamten, Date of authorisation: 26/06/2023, Revision: 5, Status: Authorised